Literature DB >> 20219583

Neurogenic temporomandibular joint dislocation treated with botulinum toxin: report of 4 cases.

Olga Vázquez Bouso1, Gabriel Forteza González, Jens Mommsen, Víctor Gumbao Grau, Javier Rodríguez Fernández, Mario Mateos Micas.   

Abstract

Many patients suffer recurrent episodes of temporomandibular joint (TMJ) dislocation due to an excess of muscle contraction or spasticity in the depressor muscles of the jaw. The manual repositioning using the Nelaton maneuver is the first treatment. Occasionally, it may be necessary to use sedation or general anesthesia to achieve the desired muscle relaxation. In case of recurrence, surgical treatment is indicated. One nonsurgical method of treatment is the local infiltration of botulinum toxin type A. We present 4 cases of recurrent TMJ dislocation in patients suffering from conditions of neurologic origin, with considerable motor deterioration, treated with local infiltration of botulinum toxin type A. In conclusion, the injection of botulinum toxin type A is an effective method in cases of neurogenic TMJ dislocation, with low morbididty and side effects, improving patients' quality of life. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219583     DOI: 10.1016/j.tripleo.2009.10.046

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  10 in total

1.  Surgical management of recurrent TMJ dislocation-a systematic review.

Authors:  Shreya Tocaciu; M J McCullough; G Dimitroulis
Journal:  Oral Maxillofac Surg       Date:  2019-02-07

Review 2.  The Treatment of Temporomandibular Joint Dislocation.

Authors:  Ulla Prechel; Peter Ottl; Oliver M Ahlers; Andreas Neff
Journal:  Dtsch Arztebl Int       Date:  2018-02-02       Impact factor: 5.594

3.  Temporomandibular joint dislocation: experiences from Zaria, Nigeria.

Authors:  Rowland Agbara; Benjamin Fomete; Athanasius Chukwudi Obiadazie; Kelvin Idehen; Uche Okeke
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2014-06-27

4.  Ultrasound-guided lateral pterygoid muscle botulinum toxin: an injection for recurrent temporomandibular joint dislocation in a brain injury patient.

Authors:  Huai-Jing Guo; Chun-Chieh Wu; Tung-Chou Li
Journal:  Oral Maxillofac Surg       Date:  2022-04-29

5.  Delayed Management of Unrecognized Bilateral Temporomandibular Joint Dislocation: A Case Report.

Authors:  Siok Yoong Chin; Nazer Bin Berahim; Khairulzaman Bin Adnan; Sundrarajan Naidu Ramasamy
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2017-04-12

6.  Positioning accuracy assessment of minimally invasive percutaneous injection techniques for the treatment of temporomandibular disorders.

Authors:  Antônio Luís Neto Custódio; Andrew Cameron; Mahmoud Bakr; Chris Little; Bruno Ramos Chrcanovic; Peter Reher
Journal:  Dentomaxillofac Radiol       Date:  2020-07-24       Impact factor: 2.419

7.  Autologous blood injection to the temporomandibular joint: magnetic resonance imaging findings.

Authors:  Celal Candirli; Serdar Yüce; Umut Yücel Cavus; Kayihan Akin; Banu Cakir
Journal:  Imaging Sci Dent       Date:  2012-03-22

Review 8.  The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review.

Authors:  Rana Ataran; Ayla Bahramian; Zahra Jamali; Vahid Pishahang; Homayoon Sadeghi Barzegani; Parvin Sarbakhsh; Javad Yazdani
Journal:  J Dent (Shiraz)       Date:  2017-09

9.  Effect of injection of botulinum toxin on decreasing the symptoms and signs of masticatory muscles in patients with temporomandibular dysfunction.

Authors:  Mohammad Ali Ghavimi; Javad Yazdani; Atena Afzalimehr; Arezoo Ghoreyshizadeh; Seyed Vahid Dehnad
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2019-08-14

10.  Botulinum Neurotoxin Injection for the Treatment of Recurrent Temporomandibular Joint Dislocation with and without Neurogenic Muscular Hyperactivity.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2018-04-25       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.